ALAmos W. H. Lim

Amos W. H. Lim

*This is an algorithmically generated author record based on publicly available information.

Amos W. H. Lim has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of Blood Glucose Measurement Using New Noninvasive Technology: Protocol and Methodology

    by Eka Widrian Suradji, Satvinder Singh Dhaliwal, Zhang Li-Feng, Entong Zhou, Amos Lim, Hui Hern Wong, Yao Du, Fredicia Fredicia, Amanda Dianky, Puspasari Pasaribu, et al.

    Background: Diabetes mellitus (DM) is a major noncommunicable disease with a significant increase in prevalence, especially in low- and middle-income countries. The latest International Diabetes Federation Diabetes Atlas (2025) reports that 11.1% of the adult population (20 to 79 years old) is living with diabetes, with over 4 in 10 unaware of their condition. Early diagnosis and treatment of diabetes reduce the risk and slow the progression of debilitating complications, such as amputation, vision loss, renal failure, cardiovascular disease, dementia, some cancers, and infections like tuberculosis and severe COVID-19. Current screening methods for diabetes are invasive and costly. This has limited their utilization, especially in high-density populations and low- and middle-income countries such as Indonesia. Blood Glucose Evaluation and Monitoring (BGEM) is a machine learning algorithm developed by Actxa to analyze photoplethysmography data from wearable devices for diabetic risk assessment. Its noninvasive and user-friendly nature makes it a strong candidate for fulfilling the need for a diabetes screening or monitoring tool. Objective: The aim of this study is to collect a large and more diverse dataset for the training of BGEM machine learning models. This dataset is intended to improve the model’s generalizability and to evaluate its performance across different age groups, racial groups, and skin types, with the goal of enhancing accuracy and robustness for diabetes risk assessment and glucose monitoring. Methods: Adult participants aged 18 years and above, with either a diabetic or a nondiabetic history, who reside in Greater Jakarta Area, Indonesia, were approached for recruitment. Blood glucose was assessed using laboratory blood analysis from capillary or plasma samples after fasting and at 1, 2, and 3 hours after a meal. BGEM data were also collected at each of these time points. Anthropological measurements with a standardized questionnaire on physical activity, demographic information, respondent’s diabetic status, and current medications taken were also collected. Results: Between June and October 2024, 885 participants were enrolled. Eight photoplethysmography recordings per participant were collected across 4 meal time points using 2 wearable devices in addition to the collection of clinical measurements, blood sampling, and related questionnaires. Conclusions: This protocol paper outlines the methodology designed for assessing and interpreting participants’ blood sugar profiles, especially on demographic variability, in order to evaluate BGEM, a photoplethysmography-based artificial intelligence model designed to estimate blood glucose levels and diabetic risk. The clinical trial was conducted on Indonesian participants with and without diabetes while considering various influencing factors. This dataset is designed to enable assessment of the model’s performance across diverse racial, risk factors, and skin-type groups, with the aim of making the model more valid and reliable.

  • Open Access

    Assessment of Blood Glucose measurement using New Non-Invasive Technology: Protocol & Methodology (Preprint)

    by Eka Widrian Suradji, Amos Lim, Entong Zhou, Zhang Li-Feng, Fredicia Fredicia, Amanda Dianky, Puspasari Pasaribu, Ernset Gamaliel Masayoshi, Mardi Santoso, Satvinder Singh Dhaliwal, et al.

    BACKGROUND Diabetes Mellitus is a major non-communicable disease with significant increase in prevalence, especially in low and middle-income countries. The latest IDF Diabetes Atlas (2025) reports that 11,1%, or about 1 in 9, of the adult population (20-79 years old) is living with diabetes, with over 4 in 10 unaware that they have the condition. This Prevalence is expected to increase to 1 in 8 adults by the year 2050. Early diagnosis and treatment of Diabetes reduces the risk and slows the progression of debilitating complications such as amputation, vision loss, and renal failure, cardiovascular disease, dementia, some cancers, and infections such as tuberculosis and severe COVID-19. Current screening methods for diabetes are invasive and costly. This has limited its more widespread utilisation especially in a high-density population, middle-low income country such as Indonesia. Blood Glucose Evaluation and Monitoring (BGEM) is a machine learning (ML) algorithm developed by Actxa to analyze Photoplethysmography (PPG) data from wearable devices for diabetic risk assessment. Its non-invasive and user-friendly nature makes it a strong candidate for fulfilling the need for a diabetes screening tool. OBJECTIVE The Aim of this study is to enhance BGEM’s performance on a large and diverse data set with an emphasis on the detailed blood sugar fluctuation, also known as glycaemic variability, under semi-controlled conditions in an Indonesian population. METHODS Adult subjects aged 18 years old and above, either with a diabetic or non-diabetic history that resides in Greater Jakarta Area, Indonesia were recruited. The study will explore BGEM blood glucose prediction capabilities compared to laboratory blood analysis from capillary or plasma samples at after fasting, 1 hour, 2 hour and 3 hours after meal. In addition to PPG and blood data collection, anthropological measurement, a standardize questionnaire on activity, demographic information and diabetic status were also conducted to provide a more complete dataset. RESULTS A total of 885 subjects were included into the study from June to October 2024, 473 were diabetic subjects and 412 were non-diabetic subjects. The blood sugar profiles of the subjects will be studied and analysed. BGEM’s performance will be assessed on this Indonesian dataset on glycaemic variability. CONCLUSIONS This protocol paper outlines the methodology designed for subject’s blood sugar profiles especially on glycaemic variability in order to evaluate BGEM, a PPG-based AI model designed to estimate blood glucose levels and diabetic risk. The clinical trial was conducted on both diabetic (DM) and non-diabetic (non-DM) Indonesian subjects, while considering various influencing factors. The results will provide objective evidence on the validity and use of a non-invasive technique for the measurement of blood sugar levels using wearables. CLINICALTRIAL Clinical trial registration NCT06642467 Institutional Review Board of Ukrida faculty of medicine & health sciences ethical committee 1779/SLKE/IM/UKKW /FKIK/KEPK /VII/2024

  • Open Access

    Assessing Elevated Blood Glucose Levels Through Blood Glucose Evaluation and Monitoring Using Machine Learning and Wearable Photoplethysmography Sensors: Algorithm Development and Validation

    by Bohan Shi, Satvinder Singh Dhaliwal, Marcus Soo, Cheri Chan, Jocelin Wong, Natalie W C Lam, Entong Zhou, Vivien Paitimusa, Kum Yin Loke, Joel Chin, et al.

    Background: Diabetes mellitus is the most challenging and fastest-growing global public health concern. Approximately 10.5% of the global adult population is affected by diabetes, and almost half of them are undiagnosed. The growing at-risk population exacerbates the shortage of health resources, with an estimated 10.6% and 6.2% of adults worldwide having impaired glucose tolerance and impaired fasting glycemia, respectively. All current diabetes screening methods are invasive and opportunistic and must be conducted in a hospital or laboratory by trained professionals. At-risk participants might remain undetected for years and miss the precious time window for early intervention to prevent or delay the onset of diabetes and its complications. Objective: We aimed to develop an artificial intelligence solution to recognize elevated blood glucose levels (≥7.8 mmol/L) noninvasively and evaluate diabetic risk based on repeated measurements. Methods: This study was conducted at KK Women’s and Children’s Hospital in Singapore, and 500 participants were recruited (mean age 38.73, SD 10.61 years; mean BMI 24.4, SD 5.1 kg/m2). The blood glucose levels for most participants were measured before and after consuming 75 g of sugary drinks using both a conventional glucometer (Accu-Chek Performa) and a wrist-worn wearable. The results obtained from the glucometer were used as ground-truth measurements. We performed extensive feature engineering on photoplethysmography (PPG) sensor data and identified features that were sensitive to glucose changes. These selected features were further analyzed using an explainable artificial intelligence approach to understand their contribution to our predictions. Results: Multiple machine learning models were trained and assessed with 10-fold cross-validation, using participant demographic data and critical features extracted from PPG measurements as predictors. A support vector machine with a radial basis function kernel had the best detection performance, with an average accuracy of 84.7%, a sensitivity of 81.05%, a specificity of 88.3%, a precision of 87.51%, a geometric mean of 84.54%, and F score of 84.03%. Conclusions: Our findings suggest that PPG measurements can be used to identify participants with elevated blood glucose measurements and assist in the screening of participants for diabetes risk.


  • Open Access

    Assessing Elevated Blood Glucose Levels Through Blood Glucose Evaluation and Monitoring Using Machine Learning and Wearable Photoplethysmography Sensors: Algorithm Development and Validation (Preprint)

    by Bohan Shi, Satvinder Singh Dhaliwal, Marcus Soo, Cheri Chan, Jocelin Wong, Natalie W C Lam, Entong Zhou, Vivien Paitimusa, Kum Yin Loke, Joel Chin, et al.

    BACKGROUND Diabetes mellitus is the most challenging and fastest-growing global public health concern. Approximately 10.5% of the global adult population is affected by diabetes, and almost half of them are undiagnosed. The growing at-risk population exacerbates the shortage of health resources, with an estimated 10.6% and 6.2% of adults worldwide having impaired glucose tolerance and impaired fasting glycemia, respectively. All current diabetes screening methods are invasive and opportunistic and must be conducted in a hospital or laboratory by trained professionals. At-risk participants might remain undetected for years and miss the precious time window for early intervention to prevent or delay the onset of diabetes and its complications. OBJECTIVE We aimed to develop an artificial intelligence solution to recognize elevated blood glucose levels (≥7.8 mmol/L) noninvasively and evaluate diabetic risk based on repeated measurements. METHODS This study was conducted at KK Women’s and Children’s Hospital in Singapore, and 500 participants were recruited (mean age 38.73, SD 10.61 years; mean BMI 24.4, SD 5.1 kg/m2). The blood glucose levels for most participants were measured before and after consuming 75 g of sugary drinks using both a conventional glucometer (Accu-Chek Performa) and a wrist-worn wearable. The results obtained from the glucometer were used as ground-truth measurements. We performed extensive feature engineering on photoplethysmography (PPG) sensor data and identified features that were sensitive to glucose changes. These selected features were further analyzed using an explainable artificial intelligence approach to understand their contribution to our predictions. RESULTS Multiple machine learning models were trained and assessed with 10-fold cross-validation, using participant demographic data and critical features extracted from PPG measurements as predictors. A support vector machine with a radial basis function kernel had the best detection performance, with an average accuracy of 84.7%, a sensitivity of 81.05%, a specificity of 88.3%, a precision of 87.51%, a geometric mean of 84.54%, and F score of 84.03%. CONCLUSIONS Our findings suggest that PPG measurements can be used to identify participants with elevated blood glucose measurements and assist in the screening of participants for diabetes risk.

  • Open Access

    Representation learning in the artificial and biological neural networks underlying sensorimotor integration

    by Ahmad Suhaimi, Amos W. H. Lim, Xin Wei Chia, Chunyue Li, Hiroshi Makino

    The integration of deep learning and theories of reinforcement learning (RL) is a promising avenue to explore novel hypotheses on reward-based learning and decision-making in humans and other animals. Here, we trained deep RL agents and mice in the same sensorimotor task with high-dimensional state and action space and studied representation learning in their respective neural networks. Evaluation of thousands of neural network models with extensive hyperparameter search revealed that learning-dependent enrichment of state-value and policy representations of the task-performance-optimized deep RL agent closely resembled neural activity of the posterior parietal cortex (PPC). These representations were critical for the task performance in both systems. PPC neurons also exhibited representations of the internally defined subgoal, a feature of deep RL algorithms postulated to improve sample efficiency. Such striking resemblance between the artificial and biological networks and their functional convergence in sensorimotor integration offers new opportunities to better understand respective intelligent systems.